EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 152 filers reported holding EDITAS MEDICINE INC in Q4 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,593,000 | +1.2% | 185,668 | 0.0% | 1.99% | -25.3% |
| Q1 2019 | $4,540,000 | +7.5% | 185,668 | 0.0% | 2.66% | -4.2% |
| Q4 2018 | $4,224,000 | -28.5% | 185,668 | 0.0% | 2.78% | -39.1% |
| Q3 2018 | $5,908,000 | -11.2% | 185,668 | 0.0% | 4.56% | -10.4% |
| Q2 2018 | $6,652,000 | +8.1% | 185,668 | 0.0% | 5.09% | +0.2% |
| Q1 2018 | $6,155,000 | +520.5% | 185,668 | +349.3% | 5.08% | +2752.8% |
| Q3 2017 | $992,000 | +43.1% | 41,324 | 0.0% | 0.18% | -3.3% |
| Q2 2017 | $693,000 | -24.8% | 41,324 | 0.0% | 0.18% | -37.0% |
| Q1 2017 | $922,000 | +37.4% | 41,324 | 0.0% | 0.29% | -5.5% |
| Q4 2016 | $671,000 | +6.3% | 41,324 | -11.7% | 0.31% | +62.6% |
| Q3 2016 | $631,000 | -56.8% | 46,775 | -21.8% | 0.19% | -65.5% |
| Q2 2016 | $1,459,000 | -83.0% | 59,800 | -75.9% | 0.55% | -81.5% |
| Q1 2016 | $8,558,000 | – | 247,768 | – | 2.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. VI, L.L.C. | 4,656,173 | $160,824,000 | 96.46% |
| Alphabet Inc. | 256,410 | $8,856,000 | 3.65% |
| Casdin Capital, LLC | 85,470 | $2,952,000 | 3.39% |
| Wildcat Capital Management, LLC | 247,768 | $8,558,000 | 2.98% |
| Omega Fund Management, LLC | 105,007 | $3,627,000 | 2.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $59,043,000 | 2.51% |
| EcoR1 Capital, LLC | 87,921 | $3,037,000 | 1.06% |
| Foresite Capital Management III, LLC | 14,500 | $501,000 | 0.39% |
| VIKING GLOBAL INVESTORS LP | 2,135,523 | $73,761,000 | 0.32% |
| Schonfeld Strategic Advisors LLC | 9,726 | $336,000 | 0.14% |